Actualités TherapeuticsMD - TXMD

Nom Action	Symbole Action	Marché	Type
TherapeuticsMD Inc	TXMD	NASDAQ	Action ordinaire

	Variation Action	Variation Action%	Cours Dernier	Dernier échange
	-0,01	-0,53%	1,88	22:30:00

Ouverture	Plus Bas	Plus Haut	Prix de clôture	Clôture Veille
1,91	1,85	1,95	1,88	1,89

Actualités Recentes

Date	Heure	Source	Titre
29/3/2024	21:00	BW	TherapeuticsMD Announces Full Year 2023 Financial Results
07/12/2023	22:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
06/12/2023	17:36	EDGAR2	Form 144 - Report of proposed sale of securities
17/11/2023	15:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
17/11/2023	15:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/11/2023	22:05	BW	TherapeuticsMD Announces Third Quarter 2023 Financial..
21/8/2023	22:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/8/2023	22:20	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
18/8/2023	23:18	EDGAR2	Form 8-K - Current report
14/8/2023	13:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/2023	13:15	EDGAR2	Form 8-K - Current report
14/8/2023	12:50	BW	TherapeuticsMD Announces Second Quarter 2023 Financial..
19/7/2023	23:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/7/2023	23:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/7/2023	23:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/7/2023	23:20	EDGAR2	Form 8-K - Current report
06/7/2023	22:38	EDGAR2	Form 8-K - Current report
30/6/2023	14:29	EDGAR2	Form SC 13D/A - General statement of acquisition of..
29/6/2023	23:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/5/2023	22:05	BW	TherapeuticsMD Announces First Quarter 2023 Financial..